Myelodysplastic Syndrome

Showing NaN - NaN of 18

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • +6 more
  • Birmingham, Alabama
  • +297 more
Jan 28, 2023

Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia

Active, not recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Birmingham, Alabama
  • +190 more
Jan 30, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts-2 Trial in United States (drug,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Anchorage, Alaska
  • +506 more
Jan 28, 2023

Collection of Tissue Samples for Cancer Research

Recruiting
  • Neoplasms
  • +3 more
  • Biopsy
  • Atlanta, Georgia
  • +9 more
Jan 23, 2023

Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

Completed
  • Acute Myeloid Leukemia
  • +19 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Lewes, Delaware
  • +16 more
Aug 3, 2022

Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in United States (biological, other, drug)

Active, not recruiting
  • Anemia
  • +3 more
  • Epoetin Alfa
  • +2 more
  • Birmingham, Alabama
  • +512 more
Mar 1, 2022

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus

Active, not recruiting
  • Acute Myelogenous Leukemia
  • +10 more
  • Atlanta, Georgia
  • +2 more
Feb 9, 2022

Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

Active, not recruiting
  • Acute Leukemia
  • +3 more
  • cytogenetic analysis
  • La Jolla, California
  • +136 more
Aug 16, 2021

Myelodysplastic Syndrome, Iron Overload Trial in Canada, United States (Deferasirox)

Completed
  • Myelodysplastic Syndrome
  • Iron Overload
  • Birmingham, Alabama
  • +47 more
Jul 21, 2021

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral

Completed
  • Myelodysplastic Syndrome
  • +2 more
  • Gilbert, Arizona
  • +12 more
Jun 15, 2021

Leukemia, Myelodysplastic Syndrome Trial in Boston, Saint Louis (AZD6738)

Recruiting
  • Leukemia
  • Myelodysplastic Syndrome
  • Boston, Massachusetts
  • +3 more
Jan 13, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Saint Louis (drug, radiation, procedure)

Terminated
  • Acute Myeloid Leukemia
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 16, 2020

Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

Completed
  • Related Donors Donating PBSC to a Family Member
  • +7 more
  • Tampa, Florida
  • +11 more
Sep 3, 2020

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in United States (Preparative Regimen, NK Cells, Interleukin-2)

Completed
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Preparative Regimen
  • +4 more
  • Atlanta, Georgia
  • +3 more
Apr 29, 2020

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Canada, United States (Co-ArgI-PEG modified human arginase I)

Completed
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Co-ArgI-PEG modified human arginase I
  • Ann Arbor, Michigan
  • +9 more
Oct 15, 2018

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome

Completed
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +5 more
  • Ipilimumab
  • Laboratory Biomarker Analysis
  • New Haven, Connecticut
  • +8 more
Mar 20, 2018

Myelodysplastic Syndrome Trial in Worldwide (eltrombopag olamine, Placebo)

Completed
  • Myelodysplastic Syndrome
  • eltrombopag olamine
  • Placebo
  • Birmingham, Alabama
  • +64 more
Nov 8, 2017